Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherry L Taylor

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Oncotarget|October 7, 2015
Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularizationRong Shao, Sherry L Taylor, Dennis S Oh, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 12, 2010
Postpartum granulomatous hypophysitis with sphenoid sinus involvement: a case studyCharalambos Demetri, Kamal C Shoukri, Sherry L Taylor, et al.
Carcinogenesis|November 28, 2013
Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastomaRong Shao, Ralph Francescone, Nipaporn Ngernyuang, et al.
The Journal of Biological Chemistry|June 2, 2012
Glioblastoma-derived tumor cells induce vasculogenic mimicry through Flk-1 protein activationRalph Francescone, Steve Scully, Brooke Bentley, et al.
The Journal of Biological Chemistry|March 10, 2011
Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastomaRalph A Francescone, Steve Scully, Michael Faibish, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 14, 2012
Transdifferentiation of glioblastoma stem-like cells into mural cells drives vasculogenic mimicry in glioblastomasSteve Scully, Ralph Francescone, Michael Faibish, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Oncotarget|October 7, 2015
Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularizationRong Shao, Sherry L Taylor, Dennis S Oh, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 12, 2010
Postpartum granulomatous hypophysitis with sphenoid sinus involvement: a case studyCharalambos Demetri, Kamal C Shoukri, Sherry L Taylor, et al.
Carcinogenesis|November 28, 2013
Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastomaRong Shao, Ralph Francescone, Nipaporn Ngernyuang, et al.
The Journal of Biological Chemistry|June 2, 2012
Glioblastoma-derived tumor cells induce vasculogenic mimicry through Flk-1 protein activationRalph Francescone, Steve Scully, Brooke Bentley, et al.
The Journal of Biological Chemistry|March 10, 2011
Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastomaRalph A Francescone, Steve Scully, Michael Faibish, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 14, 2012
Transdifferentiation of glioblastoma stem-like cells into mural cells drives vasculogenic mimicry in glioblastomasSteve Scully, Ralph Francescone, Michael Faibish, et al.
Pageof 1